ClinConnect ClinConnect Logo
Search / Trial NCT07156253

Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors

Launched by ยท

Trial Information

Current as of September 09, 2025

Recruiting

Keywords

ClinConnect Summary

This study is a Phase Ib, open-label, multicentre study of SYN818 with Olaparib administered orally in patients with locally advanced or metastatic solid tumors harboring mutations in BRCA and/or defects in the homologous recombination repair (HRR) pathway

Gender

ALL

Eligibility criteria

About

No description available.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported